|
IMT is a rapidly growing
biotechnology company building on its innovative biological
and technical perspectives and patented technologies in the
areas of cryopreservation and assisted human reproduction.
The company, established in 1995, has its headquarters in
Chester, England and a subsidiary in Israel.
In the field of veterinary
medicine, IMT has developed and markets unique
cryopreservation freezing system for animal semen that provide
substantially higher viability rates than any technology
currently available. The company’s veterinary products are
sold around the world through its Harmony CryoCare division.
In the field of human
Assisted Reproduction Technologies, IMT has developed the
EmbryoGuard
family of products designed to improve quality
assurance, safety and embryo quality in IVF laboratories.
Already included in this product group are the company’s
EmbryoGuard in-incubator monitor and the Matcher, an
innovative system for safe and thorough identification
throughout the entire IVF cycle.
Research and development is
continuing also in the area of cryopreservation for human
medical applications with exciting new directions in the areas
of tissue and organ banking.
IMT is dedicated to offering the
market superior products that will improve human medical
treatments as well as animal husbandry. In so doing, the
company employs a multidisciplinary approach combining
research and development activities in biology, other sciences
and engineering with a marketing approach that places our
customers at the forefront of our planning. |
